BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Cantor Fitzgerald
US Army

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,530,901

« Back to Dashboard

Summary for Patent: 4,530,901

Title: Recombinant DNA molecules and their use in producing human interferon-like polypeptides
Abstract:Recombinant DNA molecules and hosts transformed with them which produce polypeptides displaying a biological or immunological activity of human interferon, the gene coding for these polypeptides and methods of making and using these molecules, hosts, genes and polypeptides. The recombinant DNA molecules are characterized by structural genes that code for a polypeptide displaying a biological or immulogical activity of human interferon. In appropriate hosts these molecules permit the production and identification of genes and polypeptides displaying a biological or immunological activity of human interferon and their use in antiviral and antitumor or anticancer agents.
Inventor(s): Weissmann; Charles (Zurich, CH)
Assignee: Biogen N.V. (Curacao, AN)
Application Number:06/118,084
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 4,530,901

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
80.300079.3Jan 8, 1980

International Patent Family for Patent: 4,530,901

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria9005► Subscribe
Australia553400► Subscribe
Australia6605781► Subscribe
Bosnia and Herzegovina96096► Subscribe
Canada1341567► Subscribe
Cyprus1346► Subscribe
German Democratic Republic159782► Subscribe
German Democratic Republic203071► Subscribe
Germany3165463► Subscribe
Denmark170236► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: